|
Corral J, Hernandez-Espinosa D, Soria JM, Gonzalez-Conejero R, Ordonez A, Gonzalez-Porras JR, Perez-Ceballos E, Lecumberri R, Sanchez I, Roldan V, Mateo J, Minano A, Gonzalez M, Alberca I, Fontcuberta J, Vicente V. Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis. Blood. 2007 May 15;109(10):4258-63. Epub 2007 Jan 23. PubMed PMID: 17244682.
AÑO: 2007; IF: 10.896
|
17244682
|
Corral J, Rivera J, Guerrero JA, Miñano A, Alberca I, Hernández-Espinosa D, Ordóñez A, Martínez C, Navarro-Núñez L, González-Conejero R, Lozano ML, Vicente V. Latent and polymeric antithrombin: clearance and potential thrombotic risk. Exp Biol Med (Maywood). 2007 Feb;232(2):219-26. PubMed PMID: 17259329.
AÑO: 2007; IF: 1.979
|
|
Corral J, González-Conejero R, Hernández-Espinosa D, Vicente V. Protein Z/Z-dependent protease inhibitor (PZ/ZPI) anticoagulant system and thrombosis. Br J Haematol. 2007 Apr;137(2):99-108. Review. PubMed PMID: 17391489.
AÑO: 2007; IF: 4.49
|
|
Marín F, Roldán V, González-Conejero R, Corral J. The pharmacogenetics of antiplatelet drugs. Curr Opin Investig Drugs. 2007 Mar;8(3):213-8. Review. PubMed PMID: 17408116.
AÑO: 2007
|
|
Corral J, González-Conejero R, Soria JM, González-Porras JR, Pérez-Ceballos E, Lecumberri R, Roldán V, Souto JC, Miñano A, Hernández-Espinosa D, Alberca I, Fontcuberta J, Vicente V. A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thrombosis. Blood. 2006 Jul 1;108(1):177-83. Epub 2006 Mar 9. PubMed PMID: 16527896; PubMed Central PMCID: PMC1895831.
AÑO: 2006; IF: 10.37
|